FLT3 and acute myeloid leukemia: Furthermore, Tunicamycin C has been demonstrated to arrest under glycosylated FLT3-ITD in the endoplasmic reticulum and promote STAT5 activation in FLT3-ITD mutant cells in acute myeloid leukaemia [23].